Catalyst Wire Dossier Catalyst Wire Dossier

Vipdomet

alogliptin benzoate; metformin hydrochloride · Takeda Pharma A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vipdomet, covering 2025-05-19 to 2025-05-19. Get the full timeline:

Most recent: EMA Authorised: Vipdomet (alogliptin benzoate;metformin hydrochloride) — Takeda Pharma A/S

See pricing